Fresenius | FRE - Net Income

Stock Price
46.82
Daily Change
0.21 0.45%
Monthly
-8.41%
Yearly
17.28%
Q1 Forecast
45.46

Fresenius reported EUR361M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Akzo Nobel EUR 598M 792M Dec/2025
Alcon AG USD 217M 20M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
BASF EUR 560M 388M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Beiersdorf EUR 387M 165M Dec/2025
DaVita Healthcare Partners USD 234.22M 83.88M Dec/2025
Demant DKK 427M 690M Dec/2025
E.ON EUR 816M 867M Dec/2025
Essilor EUR 928M 459M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Getinge SEK 662M 661M Dec/2024
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GN Store Nord DKK 344M 271M Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 319M 583M Dec/2025
Novartis USD 3.93B 96M Sep/2025
Philips EUR 395M 211M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
RWE EUR 846M 183M Sep/2025
Sanofi EUR -801M 3.6B Dec/2025
Smith & Nephew USD 293M 79M Dec/2025